Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-25

Clinical Trial Update: Impact of Dexmedetomidine on the Post-Operative Cognition Dysfunction(POCD) in Geriatric Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of dexmedetomidine on postoperative cognitive dysfunction in elderly patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: The First Affiliated Hospital of Anhui Medical University | Conditions: Postoperative Confusion, Delirium | Phase 4 | Status: COMPLETED